PTPA and Alzheimer disease: Given the elevated ROS and PME-1 levels detected in AD brain tissue in contrast to healthy brain tissue, we hypothesize that these may contribute to the increased neuronal death observed in AD brain tissue, via increased PP2A-B55α inhibition and increased activation of the MAPKAPK2-RIPK1 pathway (Figure 1).